GEMVX Performance — GMO Emerging Markets Fund, Class V
Data updated: 2026-09-29
GEMVX returned +47.82% over one year to Mar 2021. Over one year the fund trailed its Emerging Markets Equity category average: $100 grew to $148, against $156 for the category. Volatility over the past 12 months was 12.27% a year. In the 12 months to May 2026 the fund lost a net $66.4M, and assets reached $587.40M.
GEMVX Growth of $100
What $100 invested in GMO Emerging Markets Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | GEMVX | Category average |
|---|---|---|
| 1 year (Apr 2020 – Mar 2021) | $148 | $156 |
| Since data start (Feb 2020 – Mar 2021) | $122 | $126 |
GEMVX Trailing Returns
Total returns to Mar 2021, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +47.82% |
GEMVX Annual Returns
Calendar-year total returns of GMO Emerging Markets Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2021 (Jan–Mar) | +6.03% |
| 2020 (Feb–Dec) | +15.00% |
GEMVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +3.1% | +1.9% | +0.9% | — | — | — | — | — | — | — | — | — |
| 2020 | — | −2.6% | −15.3% | +8.7% | +2.0% | +4.6% | +6.5% | +0.6% | −2.7% | +0.4% | +8.8% | +5.6% |
GEMVX Risk
Risk measures from monthly returns over Apr 2020 – Mar 2021.
- 1-year volatility (annualised): 12.27%
- Best month: +8.81% (Nov 2020)
- Worst month: −2.69% (Sep 2020)
GEMVX Fund Flows
Monthly money in and out of GMO Emerging Markets Fund, from SEC Form N-PORT.
- 12-month net flow: −$66.4M
- 12-month gross sales (incl. reinvestments): $116.8M
- Sales ÷ redemptions: 0.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.4M | $42.8M | −$41.5M |
| Apr 2026 | $61.1M | $64.6M | −$3.5M |
| Mar 2026 | $12.8M | $6.4M | $6.4M |
| Feb 2026 | $1.2M | $26.4M | −$25.2M |
| Jan 2026 | $5.1M | $2.1M | $3.0M |
| Dec 2025 | $23.7M | $2.7M | $21.0M |
| Nov 2025 | $3.4M | $3.3M | $85K |
| Oct 2025 | $388K | $12.6M | −$12.3M |
| Sep 2025 | $418K | $4.9M | −$4.4M |
| Aug 2025 | $5.0M | $4.6M | $438K |
| Jul 2025 | $1.3M | $5.2M | −$3.8M |
| Jun 2025 | $1.0M | $7.7M | −$6.7M |
GEMVX Assets Under Management
Net assets of GMO Emerging Markets Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $587.40M |
| 2026-02-28 | $530.11M |
| 2025-11-30 | $457.01M |
| 2025-08-31 | $447.75M |
| 2025-05-31 | $410.65M |
| 2025-02-28 | $370.55M |
| 2024-11-30 | $374.59M |
| 2024-08-31 | $401.91M |
| 2024-05-31 | $402.29M |
| 2024-02-29 | $458.38M |
| 2023-11-30 | $526.01M |
| 2023-08-31 | $708.05M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.